The trajectory of the erectile dysfunction drug presents a intricate picture for investors. While the initial introduction generated substantial gains, the expiration of its intellectual property protection opened the https://safaljxf363266.madmouseblog.com/22553963/sildenafil-and-big-pharma-a-volatile-investment